Symbols / SGHT Stock $5.19 +5.92% Sight Sciences, Inc.

Healthcare • Medical Devices • United States • NMS
SGHT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Paul Badawi
Exch · Country NMS · United States
Market Cap 282.39M
Enterprise Value 223.41M
Income -37.25M
Sales 79.55M
FCF (ttm) -8.58M
Book/sh 1.20
Cash/sh 1.56
Employees 186
Insider 10d —
IPO Jul 15, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -7.86
PEG —
P/S 3.55
P/B 4.34
P/C —
EV/EBITDA -8.27
EV/Sales 2.81
Quick Ratio 5.26
Current Ratio 5.86
Debt/Eq 77.47
LT Debt/Eq —
EPS (ttm) -0.70
EPS next Y -0.66
EPS Growth —
Revenue Growth 12.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-06
ROA -14.34%
ROE -56.64%
ROIC —
Gross Margin 86.17%
Oper. Margin -35.60%
Profit Margin -46.83%
Shs Outstand 54.41M
Shs Float 35.69M
Insider Own 20.03%
Instit Own 51.70%
Short Float 2.37%
Short Ratio 2.69
Short Interest 936.89K
52W High 9.24
vs 52W High -43.81%
52W Low 3.11
vs 52W Low 66.88%
Beta 2.38
Impl. Vol. 46.16%
Rel Volume 0.60
Avg Volume 342.86K
Volume 206.26K
Target (mean) $8.34
Tgt Median $8.50
Tgt Low $4.35
Tgt High $12.00
# Analysts 4
Recom Buy
Prev Close $4.90
Price $5.19
Change 5.92%
About

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.34
Mean price target
2. Current target
$5.19
Latest analyst target
3. DCF / Fair value
$-2.84
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.19
Low
$4.35
High
$12.00
Mean
$8.34

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-06 main UBS Buy → Buy $11
2026-03-06 main Citigroup Neutral → Neutral $7
2026-03-02 main Stifel Buy → Buy $8
2026-01-05 up Piper Sandler Neutral → Overweight $9
2025-12-23 main UBS Buy → Buy $12
2025-12-11 main Citigroup Neutral → Neutral $9
2025-12-10 main Lake Street Buy → Buy $12
2025-12-02 main Morgan Stanley Equal-Weight → Equal-Weight $8
2025-11-10 main Morgan Stanley Equal-Weight → Equal-Weight $6
2025-11-07 main Piper Sandler Neutral → Neutral $5
2025-10-21 main Lake Street Buy → Buy $7
2025-10-07 main Citigroup Neutral → Neutral $4
2025-08-28 reit Needham Hold → Hold —
2025-08-21 main Citigroup Neutral → Neutral $5
2025-08-08 up Lake Street Hold → Buy $5
2025-07-15 main Morgan Stanley Equal-Weight → Equal-Weight $4
2025-06-18 main Piper Sandler Neutral → Neutral $4
2025-05-22 main Citigroup Neutral → Neutral $4
2025-05-09 main Lake Street Hold → Hold $3
2025-04-09 reit Needham Hold → Hold —
News
RSS: Latest SGHT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-06 HAYDEN JEREMY BRAGG Officer — 13,761 $3.55 $48,852
2026-04-06 RODBERG JAMES Chief Financial Officer — 7,231 $3.55 $25,670
2026-04-02 BADAWI DAVID Chief Technology Officer — 8,168 $3.48 $28,425
2026-04-02 BAUERLEIN ALISON Chief Operating Officer — 25,874 $3.48 $90,042
2026-04-01 TAYLOR BRENTON Officer — 2,869 $3.70 $10,615
2026-04-01 BADAWI PAUL Chief Executive Officer — 29,244 $3.70 $108,203
2026-02-19 BADAWI DAVID Chief Technology Officer — 21,270 $0.23 $4,892
2026-02-03 TAYLOR BRENTON Officer — 100,464 $0.00 $0
2026-02-03 HAYDEN JEREMY BRAGG Officer — 115,920 $0.00 $0
2026-02-03 BADAWI DAVID Chief Technology Officer — 64,915 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
77.36
-3.13%
79.87
-1.47%
81.06
+13.63%
71.33
Operating Revenue
77.36
-3.13%
79.87
-1.47%
81.06
+13.63%
71.33
Cost Of Revenue
10.70
-7.63%
11.58
-2.53%
11.88
-3.88%
12.36
Reconciled Cost Of Revenue
10.70
-7.63%
11.58
-2.53%
11.88
-3.88%
12.36
Gross Profit
66.67
-2.37%
68.28
-1.29%
69.17
+17.31%
58.97
Operating Expense
103.77
-12.67%
118.82
-6.04%
126.45
-11.53%
142.92
Research And Development
14.61
-18.81%
17.99
+2.48%
17.56
-23.20%
22.86
Selling General And Administration
89.16
-11.57%
100.83
-7.41%
108.89
-9.30%
120.06
Total Expenses
114.46
-12.22%
130.40
-5.73%
138.33
-10.92%
155.28
Operating Income
-37.10
+26.58%
-50.53
+11.77%
-57.27
+31.78%
-83.95
Total Operating Income As Reported
-37.10
+26.58%
-50.53
+11.77%
-57.27
+31.78%
-83.95
EBITDA
-32.79
+28.56%
-45.90
+7.12%
-49.41
+39.01%
-81.02
Normalized EBITDA
-36.76
+26.26%
-49.85
+12.08%
-56.70
+30.01%
-81.02
Reconciled Depreciation
0.49
-31.60%
0.71
+15.96%
0.61
-13.52%
0.71
EBIT
-33.27
+28.61%
-46.61
+6.84%
-50.03
+38.79%
-81.73
Total Unusual Items
3.97
+0.46%
3.96
-45.74%
7.29
—
Total Unusual Items Excluding Goodwill
3.97
+0.46%
3.96
-45.74%
7.29
—
Special Income Charges
0.00
+100.00%
-1.96
0.00
—
Other Special Charges
—
1.96
—
—
Net Income
-38.43
+25.40%
-51.51
+7.27%
-55.55
+35.59%
-86.24
Pretax Income
-38.42
+25.07%
-51.27
+7.51%
-55.44
+35.68%
-86.19
Net Non Operating Interest Income Expense
-5.14
-10.30%
-4.66
+13.79%
-5.41
-21.09%
-4.47
Interest Expense Non Operating
5.14
+10.30%
4.66
-13.79%
5.41
+21.09%
4.47
Net Interest Income
-5.14
-10.30%
-4.66
+13.79%
-5.41
-21.09%
-4.47
Interest Expense
5.14
+10.30%
4.66
-13.79%
5.41
+21.09%
4.47
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
3.83
-2.50%
3.92
-45.85%
7.25
+225.62%
2.23
Other Non Operating Income Expenses
-0.15
-362.50%
-0.03
+27.27%
-0.04
-101.98%
2.23
Gain On Sale Of Security
3.97
-32.85%
5.92
-18.82%
7.29
—
Tax Provision
0.01
-95.76%
0.24
+114.55%
0.11
+134.04%
0.05
Tax Rate For Calcs
0.00
-100.00%
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
-100.00%
0.83
0.00
0.00
Net Income Including Noncontrolling Interests
-38.43
+25.40%
-51.51
+7.27%
-55.55
+35.59%
-86.24
Net Income From Continuing Operation Net Minority Interest
-38.43
+25.40%
-51.51
+7.27%
-55.55
+35.59%
-86.24
Net Income From Continuing And Discontinued Operation
-38.43
+25.40%
-51.51
+7.27%
-55.55
+35.59%
-86.24
Net Income Continuous Operations
-38.43
+25.40%
-51.51
+7.27%
-55.55
+35.59%
-86.24
Normalized Income
-42.40
+22.39%
-54.63
+13.06%
-62.84
+27.14%
-86.24
Net Income Common Stockholders
-38.43
+25.40%
-51.51
+7.27%
-55.55
+35.59%
-86.24
Diluted EPS
—
-1.03
+9.65%
-1.14
+36.67%
-1.80
Basic EPS
—
-1.03
+9.65%
-1.14
+36.67%
-1.80
Basic Average Shares
—
50.13
+3.10%
48.63
+1.63%
47.85
Diluted Average Shares
—
50.13
+3.10%
48.63
+1.63%
47.85
Diluted NI Availto Com Stockholders
-38.43
+25.40%
-51.51
+7.27%
-55.55
+35.59%
-86.24
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
115.30
-19.28%
142.84
-14.29%
166.65
-21.79%
213.07
Current Assets
112.73
-19.35%
139.77
-14.18%
162.87
-22.32%
209.68
Cash Cash Equivalents And Short Term Investments
91.97
-23.59%
120.36
-12.87%
138.13
-25.34%
185.00
Cash And Cash Equivalents
91.97
-23.59%
120.36
-12.87%
138.13
-25.34%
185.00
Receivables
9.74
-9.65%
10.79
-24.52%
14.29
-5.67%
15.15
Accounts Receivable
9.74
-9.65%
10.79
-24.52%
14.29
-5.67%
15.15
Gross Accounts Receivable
9.98
-13.04%
11.47
-25.85%
15.47
-4.31%
16.17
Allowance For Doubtful Accounts Receivable
-0.23
+66.04%
-0.69
+41.91%
-1.19
-15.82%
-1.02
Inventory
7.77
+22.80%
6.33
-19.42%
7.85
+28.38%
6.11
Raw Materials
1.20
+20.00%
1.00
+0.00%
1.00
+150.00%
0.40
Finished Goods
6.80
+21.43%
5.60
-23.29%
7.30
+25.86%
5.80
Prepaid Assets
—
—
—
—
Other Current Assets
3.26
+41.24%
2.31
-11.44%
2.60
-23.75%
3.42
Total Non Current Assets
2.57
-16.28%
3.06
-18.92%
3.78
+11.31%
3.40
Net PPE
2.05
-18.57%
2.52
-18.82%
3.10
-2.73%
3.19
Gross PPE
4.45
-3.72%
4.62
-2.20%
4.72
+2.29%
4.62
Accumulated Depreciation
-2.40
-14.01%
-2.11
-29.44%
-1.63
-13.46%
-1.43
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.50
+13.44%
0.44
+21.94%
0.36
+12.85%
0.32
Construction In Progress
1.26
+3.45%
1.22
+41.79%
0.86
+80.84%
0.47
Other Properties
2.65
-9.33%
2.93
-15.63%
3.47
-8.42%
3.79
Leases
0.04
+0.00%
0.04
+0.00%
0.04
+0.00%
0.04
Other Non Current Assets
0.52
-5.82%
0.55
-19.35%
0.68
+223.22%
0.21
Total Liabilities Net Minority Interest
51.36
-7.16%
55.32
+19.12%
46.44
-12.38%
53.00
Current Liabilities
11.03
-28.71%
15.47
+26.25%
12.25
-31.23%
17.82
Payables And Accrued Expenses
4.48
-14.79%
5.25
+6.55%
4.93
-47.70%
9.43
Payables
1.34
-20.58%
1.69
-2.31%
1.73
-35.60%
2.69
Accounts Payable
1.34
-20.58%
1.69
-2.31%
1.73
-35.60%
2.69
Current Accrued Expenses
3.13
-12.04%
3.56
+11.34%
3.20
-52.52%
6.74
Pensionand Other Post Retirement Benefit Plans Current
6.07
-37.25%
9.68
+113.78%
4.53
-38.41%
7.35
Current Debt And Capital Lease Obligation
0.47
-10.88%
0.53
-80.91%
2.79
+170.28%
1.03
Current Debt
—
—
2.22
—
Other Current Borrowings
—
—
2.22
—
Current Capital Lease Obligation
0.47
-10.88%
0.53
-6.98%
0.57
-44.53%
1.03
Other Current Liabilities
—
—
—
0.00
Total Non Current Liabilities Net Minority Interest
40.33
+1.21%
39.85
+16.57%
34.18
-2.83%
35.18
Long Term Debt And Capital Lease Obligation
40.30
+1.18%
39.83
+22.09%
32.62
-3.91%
33.95
Long Term Debt
40.30
+2.40%
39.36
+24.12%
31.71
-4.82%
33.31
Long Term Capital Lease Obligation
0.00
-100.00%
0.47
-48.25%
0.91
+43.94%
0.64
Tradeand Other Payables Non Current
—
0.00
-100.00%
1.52
+27.64%
1.19
Other Non Current Liabilities
0.03
+63.16%
0.02
-50.00%
0.04
+0.00%
0.04
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
63.94
-26.94%
87.52
-27.19%
120.22
-24.90%
160.08
Common Stock Equity
63.94
-26.94%
87.52
-27.19%
120.22
-24.90%
160.08
Capital Stock
0.05
+5.88%
0.05
+4.08%
0.05
+2.08%
0.05
Common Stock
0.05
+5.88%
0.05
+4.08%
0.05
+2.08%
0.05
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
53.49
+5.02%
50.94
+3.68%
49.13
+1.73%
48.30
Ordinary Shares Number
53.49
+5.02%
50.94
+3.68%
49.13
+1.73%
48.30
Additional Paid In Capital
448.61
+3.42%
433.77
+4.53%
414.96
+3.93%
399.27
Retained Earnings
-384.72
-11.10%
-346.30
-17.47%
-294.79
-23.22%
-239.24
Total Equity Gross Minority Interest
63.94
-26.94%
87.52
-27.19%
120.22
-24.90%
160.08
Total Capitalization
104.24
-17.84%
126.88
-16.48%
151.92
-21.44%
193.39
Working Capital
101.71
-18.18%
124.31
-17.47%
150.62
-21.50%
191.86
Invested Capital
104.24
-17.84%
126.88
-17.69%
154.14
-20.29%
193.39
Total Debt
40.77
+1.02%
40.36
+13.97%
35.41
+1.24%
34.98
Capital Lease Obligations
0.47
-52.78%
1.01
-32.35%
1.49
-10.85%
1.67
Net Tangible Assets
63.94
-26.94%
87.52
-27.19%
120.22
-24.90%
160.08
Tangible Book Value
63.94
-26.94%
87.52
-27.19%
120.22
-24.90%
160.08
Derivative Product Liabilities
—
—
—
—
Interest Payable
0.36
+3.78%
0.34
-8.27%
0.38
+7.76%
0.35
Inventories Adjustments Allowances
-0.30
+0.00%
-0.30
+40.00%
-0.50
-400.00%
-0.10
Other Inventories
0.07
+168.00%
0.03
-48.98%
0.05
+250.00%
0.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-29.69
-32.85%
-22.35
+52.63%
-47.18
+37.89%
-75.97
Cash Flow From Continuing Operating Activities
-29.69
-32.85%
-22.35
+52.63%
-47.18
+37.89%
-75.97
Net Income From Continuing Operations
-38.43
+25.40%
-51.51
+7.27%
-55.55
+35.59%
-86.24
Depreciation Amortization Depletion
0.49
-31.60%
0.71
+15.96%
0.61
-13.52%
0.71
Depreciation
—
—
0.61
-13.52%
0.71
Depreciation And Amortization
0.49
-31.60%
0.71
+15.96%
0.61
-13.52%
0.71
Other Non Cash Items
1.44
+3.07%
1.40
-13.64%
1.62
+35.11%
1.20
Stock Based Compensation
13.05
-23.56%
17.08
+17.12%
14.58
+12.48%
12.96
Provisionand Write Offof Assets
0.13
+187.16%
-0.15
-124.03%
0.62
-39.37%
1.02
Operating Gains Losses
0.01
-98.66%
1.12
+1590.91%
0.07
-22.35%
0.09
Gain Loss On Investment Securities
0.01
-81.67%
0.06
—
—
Gain Loss On Sale Of PPE
0.00
-82.61%
0.02
-65.15%
0.07
-22.35%
0.09
Change In Working Capital
-6.39
-171.06%
9.00
+198.53%
-9.13
-60.36%
-5.70
Change In Receivables
0.91
-74.27%
3.54
+436.31%
0.66
+109.66%
-6.84
Changes In Account Receivables
0.91
-74.27%
3.54
+436.31%
0.66
+109.66%
-6.84
Change In Inventory
-1.44
-188.47%
1.63
+175.60%
-2.16
+33.72%
-3.25
Change In Prepaid Assets
-0.69
-329.43%
0.30
-63.18%
0.81
+8.12%
0.75
Change In Payables And Accrued Expense
-5.03
-197.84%
5.14
+161.85%
-8.31
-351.54%
3.30
Change In Accrued Expense
-4.68
-197.44%
4.80
+164.67%
-7.43
-285.79%
4.00
Change In Payable
-0.35
-203.57%
0.34
+138.05%
-0.88
-27.23%
-0.69
Change In Account Payable
-0.35
-203.57%
0.34
+138.05%
-0.88
-27.23%
-0.69
Change In Other Working Capital
—
—
—
1.36
Change In Other Current Assets
-0.15
-194.12%
-0.05
+89.15%
-0.47
-4600.00%
-0.01
Change In Other Current Liabilities
0.00
+100.00%
-1.56
-573.64%
0.33
-6.52%
0.35
Investing Cash Flow
-0.22
+41.82%
-0.39
+51.33%
-0.79
+18.45%
-0.97
Cash Flow From Continuing Investing Activities
-0.22
+41.82%
-0.39
+51.33%
-0.79
+18.45%
-0.97
Net PPE Purchase And Sale
-0.22
+41.82%
-0.39
+51.33%
-0.79
+18.45%
-0.97
Purchase Of PPE
-0.22
+41.82%
-0.39
+51.33%
-0.79
+18.45%
-0.97
Capital Expenditure
-0.22
+41.82%
-0.39
+51.33%
-0.79
+18.45%
-0.97
Financing Cash Flow
1.79
-63.92%
4.96
+349.64%
1.10
-11.54%
1.25
Cash Flow From Continuing Financing Activities
1.79
-63.92%
4.96
+349.64%
1.10
-11.54%
1.25
Net Issuance Payments Of Debt
0.00
-100.00%
4.15
0.00
—
Issuance Of Debt
0.00
-100.00%
39.53
0.00
—
Repayment Of Debt
0.00
+100.00%
-35.38
0.00
—
Long Term Debt Issuance
0.00
-100.00%
39.53
0.00
—
Long Term Debt Payments
0.00
+100.00%
-35.38
0.00
—
Net Long Term Debt Issuance
0.00
-100.00%
4.15
0.00
—
Net Common Stock Issuance
—
—
—
0.00
Proceeds From Stock Option Exercised
1.85
+72.16%
1.07
-19.13%
1.33
+6.41%
1.25
Net Other Financing Charges
-0.06
+77.78%
-0.26
-16.52%
-0.22
—
Changes In Cash
-28.13
-58.27%
-17.77
+62.08%
-46.87
+38.07%
-75.69
Beginning Cash Position
120.36
-12.87%
138.13
-25.34%
185.00
-29.03%
260.69
End Cash Position
92.23
-23.37%
120.36
-12.87%
138.13
-25.34%
185.00
Free Cash Flow
-29.92
-31.59%
-22.74
+52.61%
-47.98
+37.64%
-76.94
Interest Paid Supplemental Data
4.18
-1.81%
4.26
-0.12%
4.27
+31.21%
3.25
Common Stock Issuance
—
—
—
0.00
Issuance Of Capital Stock
—
—
—
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category